Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-lin Li

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Acta Pharmacologica Sinica|November 30, 2018
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesisZhuo Chen, Lin-Jiang Tong, Bai-You Tang, et al.
Fitoterapia|October 30, 2012
Bioactive phenolics and terpenoids from Manglietia insignisShan-Zhai Shang, Ling-Mei Kong, Li-Ping Yang, et al.
Planta Medica|January 28, 2012
Lanostane triterpenoids from the stems of Schisandra glaucescensJuan Zou, Li-Bin Yang, Jing Jiang, et al.
Acta Pharmacologica Sinica|August 19, 2024
Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1ATong Zhao, Zhi-Ruo Zhou, Hui-Qi Wan, et al.
Journal of Medicinal Chemistry|July 10, 2008
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screeningLi-Gen Lin, Hua Xie, Hong-Lin Li, et al.
Oncology Letters|October 4, 2019
MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1Hong-Lin Li, Jun-Jie Sun, Hui Ma, et al.
Oncology Letters|September 18, 2023
Erratum: [Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1Hong-Lin Li, Jun-Jie Sun, Hui Ma, et al.
Acta Pharmacologica Sinica|April 28, 2021
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitorsPeng-Xuan Ren, Wei-Juan Shang, Wan-Chao Yin, et al.
BMJ Open|April 13, 2023
Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trialInes Kralj-Hans, Kuo Li, Adrian Wesek, et al.
Chinese Journal of Integrative Medicine|October 10, 2020
Efficacy of Getong Tongluo Capsule () for Convalescent-Phase of Ischemic Stroke and Primary Hypertension: A Multicenter, Randomized, Double-Blind, Controlled TrialQian-Yu Zhao, Rong-Hua Tang, Guo-Xiong Lu, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Acta Pharmacologica Sinica|November 30, 2018
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesisZhuo Chen, Lin-Jiang Tong, Bai-You Tang, et al.
Fitoterapia|October 30, 2012
Bioactive phenolics and terpenoids from Manglietia insignisShan-Zhai Shang, Ling-Mei Kong, Li-Ping Yang, et al.
Planta Medica|January 28, 2012
Lanostane triterpenoids from the stems of Schisandra glaucescensJuan Zou, Li-Bin Yang, Jing Jiang, et al.
Acta Pharmacologica Sinica|August 19, 2024
Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1ATong Zhao, Zhi-Ruo Zhou, Hui-Qi Wan, et al.
Journal of Medicinal Chemistry|July 10, 2008
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screeningLi-Gen Lin, Hua Xie, Hong-Lin Li, et al.
Oncology Letters|October 4, 2019
MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1Hong-Lin Li, Jun-Jie Sun, Hui Ma, et al.
Oncology Letters|September 18, 2023
Erratum: [Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1Hong-Lin Li, Jun-Jie Sun, Hui Ma, et al.
Acta Pharmacologica Sinica|April 28, 2021
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitorsPeng-Xuan Ren, Wei-Juan Shang, Wan-Chao Yin, et al.
BMJ Open|April 13, 2023
Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trialInes Kralj-Hans, Kuo Li, Adrian Wesek, et al.
Chinese Journal of Integrative Medicine|October 10, 2020
Efficacy of Getong Tongluo Capsule () for Convalescent-Phase of Ischemic Stroke and Primary Hypertension: A Multicenter, Randomized, Double-Blind, Controlled TrialQian-Yu Zhao, Rong-Hua Tang, Guo-Xiong Lu, et al.
Pageof 7